Corvus Pharmaceuticals Inc (NASDAQ:CRVS)
| 2.57 Delayed Data As of Jul 02 |  -0.08 / -3.02%Today’s Change | 1.01 Today|||52-Week Range 8.10 | -52.76% Year-to-Date |
Latest CRVS News | Press Releases
No recent news for Corvus Pharmaceuticals Inc.
Today’s Trading
| Previous close | 2.65 |
| Today’s open | 2.61 |
| Day’s range | 2.55 - 2.61 |
| Volume | 1,291 |
| Average volume (3 months) | 141,374 |
| Market cap | $80.5M |
Data as of 3:59pm ET, 07/02/2020
Growth & Valuation
| Earnings growth (last year) | +6.80% |
| Earnings growth (this year) | +27.67% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.13 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ADMSAdamas Pharmaceutica... | -0.13 | -4.78% |
| SCYXSCYNEXIS Inc | -0.02 | -2.08% |
| GWPDGP Solutions Inc | +0.08 | +10.00% |
| SESNSesen Bio Inc | -0.01 | -1.57% |
Data as of 4:03pm ET, 07/02/2020
Financials
| Next reporting date | July 30, 2020 |
| EPS forecast (this quarter) | -$0.28 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$46.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Burlingame, California |
Forecasts
